FPSO Maria Quitéria heads to Brazil for Petrobras’ Jubarte field

Must Read

OilNOW is an online-based Information and Resource Centre

The floating production storage and offloading (FPSO) unit Maria Quitéria, built by Malaysian supplier Yinson, has departed China and is en route to Brazil. It will be deployed at Petrobras’ Jubarte field in the Campos Basin.

The FPSO Maria Quitéria left China in May and is expected to arrive in Brazil in the third quarter of 2024. The unit is scheduled to begin operations in the last quarter of the year, ahead of the planned start in 2025.

Petrobras receives OTC award for innovations in Campos Basin revitalization | OilNOW 

The Jubarte field is located in the Campos Basin’s pre-salt layer, off the coast of Espírito Santo. The FPSO Maria Quitéria has a production capacity of 100,000 barrels of oil and can process 5 million cubic meters of gas. It has decarbonization technologies, including a combined cycle power generation system and a closed flare gas recovery unit (FGRU).

Petrobras chartered the FPSO from Yinson, which also handled its construction under a contract agreed upon in 2022. The FPSO will be part of the Parque das Baleias Integrated Project offshore Brazil. This area comprises the Jubarte, Baleia Anã, Cachalote, Caxaréu, Pirambú, and Mangangá fields. Jubarte, the first field, was discovered in 2001.

Petrobras adds 80,000 bpd to Campos basin output | OilNOW 

In 2019, Petrobras and the National Agency of Petroleum, Natural Gas and Biofuels (ANP) agreed to extend the concession term for the unified Jubarte field until 2056. This extension enables the implementation of the new production system for the Parque das Baleias Integrated Project and other complementary projects in the area.


Partnered Events

Latest News

Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing Loss

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel...

More Articles Like This